GOVX Financials 07/16/2014 00:48:52
GeoVax Labs, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 2,418 2,657 4,900 5,185
Cost of Revenue - - - -
Gross Profit 2,418 2,657 4,900 5,185
Operating Expenses
Research and Development 2,915 3,044 4,276 4,794
Sales, General and Admin. 1,792 1,753 2,973 3,162
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,289) (2,139) (2,349) (2,771)
Income From Continuing Operations
Add'l Income/Expense Items 5 4 2 24
Earnings Before Interest and Tax (2,285) (2,135) (2,347) (2,747)
Interest Expense - - - -
Earnings Before Tax (2,285) (2,135) (2,347) (2,747)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,285) (2,135) (2,347) (2,747)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,285) (2,135) (2,347) (2,747)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,285) (2,135) (2,347) (2,747)